Induced native phage therapy
PhagenCorp is advancing a new way to think about whole-body wellness with induced native phage therapy. This educational overview is designed to help you understand what native phages are, how they may support the body’s internal balance, and why this approach is drawing interest from patients and providers who want innovative, non-toxic options. Rather than focusing on suppressing symptoms alone, induced native phage therapy explores how the body’s own biological systems may be encouraged to work more effectively.
What are native phages?
Native phages are naturally occurring bacteriophages, which are tiny biological entities found throughout the human body and environment. In broad terms, bacteriophages interact with microbes, and researchers continue to study how these relationships may influence the body’s terrain and immune resilience. At PhagenCorp, native phages are understood as part of the body’s existing biological landscape, where they may play a role in helping the body address unwanted microbial activity.
Because phages are already present in the human ecosystem, they represent an intriguing area of research for those interested in supportive, non-invasive approaches. Rather than introducing broad external agents, this model focuses on activating what may already be there. That concept is central to induced native phage therapy and helps explain why the approach has attracted attention from people seeking integrative care options.
What is induced native phage therapy?
The idea behind induced native phage therapy is simple, even if the biology is complex. Instead of relying on heavy external interventions, the therapy aims to awaken dormant native phages so they can participate more actively in the body’s internal cleanup processes. This may help the body respond to a range of unwanted materials, including microbes, toxins, viral particles, and other stressors that can contribute to imbalance.
PhagenCorp’s Indicen® formulas are designed to deliver subtle informational signals through oral nanoparticle suspensions. These formulas are described as non-toxic and non-allergenic, and they are intended to work alongside most health protocols. The emphasis is on gentle support, not harsh disruption, which is one reason the approach appeals to patients who are seeking more biologically respectful options.
Potential benefits of induced native phage therapy
When native phages are activated, the theory is that they may help clear out harmful objects that contribute to biological stress. Those objects include microbial imbalances, toxins, viruses, and other forms of internal burden. While every person’s situation is unique, PhagenCorp has seen interest in this approach from individuals dealing with complex, ongoing health challenges.
Reported areas of support have included gut imbalances, parasites, respiratory infections, Lyme-related concerns, CIRS, UTIs, and other chronic or recurring issues. It is important to note that these are not guarantees or universal outcomes. Instead, they reflect the kinds of concerns for which patients and practitioners often seek a more integrative, supportive model.
- Supports a non-toxic, non-allergenic wellness approach
- Focuses on activating the body’s native biology
- Designed to complement many existing health protocols
- May be useful in complex, chronic, or treatment-resistant cases
For people who have tried many external interventions without lasting success, the appeal of this model is clear. It does not replace the need for individualized care, but it may offer a new avenue for discussion with a qualified provider.
Developed by Dr. Jernigan
Induced native phage therapy, as developed by Dr. Jernigan, reflects years of research, clinical observation, and innovation. Jernigan is recognized as a founder, researcher, and biotech leader whose work has helped shape the conversation around natural support for complex, treatment-resistant health challenges. He was the first to publish a book on the natural treatment of people suffering from treatment-resistant Lyme disease and is the author of five books, including the best-selling Beating Lyme Disease, 2nd Edition.
His work has helped bring attention to approaches that consider the body’s own healing intelligence rather than relying exclusively on external suppression. PhagenCorp continues this mission by helping make the therapy more accessible and by expanding awareness among patients and practitioners across the world. There is still more work to be done, but the goal remains clear: to support broader access to a thoughtful, science-informed, non-toxic option.
8 FAQs on induced native phage therapy
